The technology company Futurs offers work to Ukranian asylum seekers in Spain

The technology company Futurs offers work to Ukranian asylum seekers in Spain

by | Mar 21, 2022 | Uncategorized | 0 comments

  • The program offers positions for software development, IT operations and system administration profiles who’ll work on international projects, although it’s open to finding positions that best suit the candidates’s profiles.
  • Futurs is commited to offering the recruits an individual training plan, Spanish language teachers, logistical and financial assistance to settle in Spain and medical advice through Minds, its emotional well-being service , as well as support from their colleagues within the company.

MADRID, MARCH 21, 2022 – In compliance with its commitment to the Sustainable Development Goals of the 2030 Agenda, Futurs, the technology division of the Ribera healthcare group, has activated a new fast-track employment opportunities program aimed at Ukrainian citizens who had to leave their country due to the crisis in Ukraine. Thanks to this program, the company is speeding up its application, assessment, interview and selection processes to facilitate the hiring of Ukrainians relocated to Spain, supporting them during all phases of the process (including paperwork, relocation and adaptation) and always maintaining all legal guarantees.

The profiles offered by Futurs are software development, IT operations and system administrators. In both cases, they‘ll be working on international projects in a English speaking environment. However, the leading technology company in the healthcare sector is open to finding specific positions that best suit the profiles of the candidates.

The people hired will receive an individual training plan from Futurs so that they can obtain the necessary knowledge for their work and their development. In the event that they don’t speak Spanish, they’ll be able to count on teachers who’ll teach them the language to facilitate their adaptation to their new place of residence.

ASSISTANCE IN THE ADAPTATION PROCESS

Futurs will help in everything necessary for the recolated Ukrainian citizens to move with all the guarantees to Alicante/Elche, Spain. From the beginning, the company will help in all the necessary initial steps so that both the selected people and their families can settle down without any problems. To this end, both logistical and financial assistance will be offered for the search and access to housing, as well as for settling in.

Within the company, new recruits will have a buddy, a colleague who’ll accompany them at all times during their onboarding process in the company. They’ll also have the People Management Department and the Legal Department at their disposal, with the aim of facilitating as much as possible both the adaptation and the necessary steps during the process. In addition, Futurs offers the possibility of receiving individual medical support to help maintain the emotional well-being of the person.

ABOUT FUTURS

Futurs is the technological division of the Ribera healthcare group. Founded in 2019 as a new concept of responsible health, it unites the vision and clinical experience of more than 20 years of the Ribera healthcare group and the most innovative technology, with proprietary solutions and a clear commitment to co-innovation, to provide an optimal and comprehensive response to the healthcare needs of health professionals and the current and future population.

Futurs’ objective is to improve and innovate the technology associated with healthcare, in order to achieve better levels of health and well-being for people. We develop technology that helps to improve healthcare and healthcare excellence. In addition, we’re aligned with the Sustainable Development Goals (SDGs) and the 2030 Agenda, to contribute to the local and economic development of our environment and add value to society.

Ribera Lab measures the cellular immune response to Covid with a new test in order to know the effects of the vaccine or infection

Ribera Lab measures the cellular immune response to Covid with a new test in order to know the effects of the vaccine or infection

by | Mar 9, 2022 | Ribera | 0 comments

  • This test, which consists of small extraction of blood, is meant for patients with compromised immune systems who want to check their level of immunity, but also for people who want to evaluate the effectiveness of the vaccine or the consequences of Covid on their immune system.
  • This test is currently carried out in the laboratories at Alicante’s Immunology Center (Elche), Ribera Povisa Hospital (Vigo) and Juan Cardona Hospital (Ferrol).

Ribera Lab, Ribera healthcare group‘s laboratory division, has incorporated a new test into their portfolio of services which assesses a person’s cellular immune response to Covid. With this test, anyone can know the state of their immune system to combat the virus, after having been vaccinated or infected, although the test is aimed especially at patients with compromised immune systems and groups that are especially vulnerable to Covid.

As the Ribera Lab specialists explain, “there are two types of acquired adaptive immune response, humoral and cellular”. The cellular response to SARS-CoV-2 usually appears alongside the humoral response, through antibodies, although it usually lasts longer and is more sensitive”, they add, given that “it has been seen to be prevalent in asymptomatic patients, those with mild symptoms or even those that have barely generated any antibodies that are measureable with specific techniques”.

“The T lymphocytes or T cells form part of the cellular immune response and are the main defense mechanism against intracellular microorganisms”, explain the specialists from  Ribera group’s laboratory division. In fact, the response from the T cells when faced with a real infection and when the Covid vaccine is administered is similar. Contact with SARA-CoV-2 triggers the cellular response of the T lymphoctyes, which when stimulated by viral antigens, amongst others, release what is known as Interferon Gamma (INF-y)”, they affirm.

There are still a lot of unknowns surrounding the transmission of this virus and its variants, as well as the different immune system response of each person when they are infected. However, advances and developments regarding these types of serological tests allow us to provide more information to patients that are particularly vulnerable to Covid or those that want to know the cellular immunity generated after administering the vaccines, after having had the infection or the combination of both. Ribera Lab’s specialists explain: “The cellular response compliments the determination of antibodies and allows us to evaluate the response of patients with positive serology, that have had Covid-19 or have been vaccinated; to assess immunity in patients with compromised immune systems; and evaluate the effectiveness of the vaccine”. And they add that “due to the nature of the test itself, it is especially suitable for patients with the suspicion or knowledge of having had Covid or those that have not produced antibodies having been vaccinated.”

But anyone can clear up any doubts with this test, consisting of a small extraction of blood, available in the centers that Ribera Lab has in Ribera Povisa Hospital (Vigo), Juan Cardona Hospital (Ferrol) and at the Alicante’s Immunology Center (Elche). The test to determine the degree of immunization is carried out by exposing a concentration of the patient’s lymphocytes to a protein extract of SARS-CoV-2 antigens (protein P, N, M and S), and, using the ELISA technique, the release of Interferon Gamma INF-y from the blood’s T lymphocytes is detected.